| Special Reports |
| Initiating Coverage |
| TeamLease Services: Team up with this |
| | Structural play on rising organized sector employment in India | | | Industry leading market share and strong management are key positives | | | Forecast strong PAT CAGR of 37% over FY2016-19E and steady FCF generation | | | Key risks: high competitive intensity, change in labor laws, economic growth slowdown | |
| Strategy |
| Strategy: Bottom of the barrel |
| | 1QFY17 results decent at net level helped by non-operating factors in several cases | | | Volume growth continues to be sluggish; summer months may have aggravated demand | | | Demand will hopefully pick up on good monsoons and 7CPC-related payouts | | | Valuations are expensive based on any reasonable parameter or timeframe | |
| Daily Alerts |
| Results |
| ICICI Bank: Walking wounded |
| | Earnings take the brunt of high slippages | | | NPLs arising mainly from the sub-investment portfolio and restructured loans | | | There are probably a few tricks up the sleeve in 2HFY16 | | | We continue to maintain our positive view | |
| L&T: New accounting norms - confusion galore |
| | 1QFY17 below estimate led by Ind-AS changes and weak financials in RE, MMH, shipbuilding | | | Ind AS - ECL provision components (non-cash) have material impact | | | Revise estimates; Maintain Reduce | |
| Eicher Motors: Strong quarter |
| | Adoption of Ind-AS: VECV to be accounted under equity method, fair value accounting of ESOP | | | Consolidated results above estimates on stronger performance of Royal Enfield business | | | Increase FY2017-19 consolidated EPS estimates by 4%; maintain SELL on expensive valuations | |
| Vedanta: In line, but divergent across businesses |
| | Consolidated EBIDTA in line though standalone weaker than expected | | | Consolidated net debt increases by Rs64 bn due to payment of dividend at HZ | | | Ramp-up of aluminum, power progresses well and will drive volume growth over FY2017-18E | |
| UPL: Soft start |
| | Revenue growth momentum sees moderation in both ag-chem and seeds businesses | | | Management sees growth improving in coming quarters; keeps guidance in-tact | | | Increase estimates TP to Rs660 (Rs600 earlier); Recommend ADD | |
| Cholamandalam: Mixed performance |
| | PAT up 50% yoy | | | Vehicle finance (VF) remains in sweet spot | | | Headwinds for LAP/home equity (HE) business | | | Retain REDUCE; TP Rs1,010 | |
| Hexaware Technologies: Focus areas power 2Q performance |
| | BPO and IMS power growth; financial services resilient; EBIT margin disappoints | | | Focus bets paying off; quarterly volatility will remain though | | | Dividend cut not a surprise; maintain ADD rating | |
| KEC International: On the path to recovery |
| | In-line EBITDA; higher interest cost and Ind-AS-induced higher tax rate mar PAT | | | Improving operations of SAE and prospects in domestic market bode well for FY2017; retains guidance | | | Revise estimates to build the miss in 1QFY17 | |
| Results, Change in Reco |
| Nestle India: Market minus performance in a weak market = lackluster quarter |
| | 2QCY16 - weak earnings print unless one stretches the 'benefit of doubt' argument | | | Downgrade to SELL as we trim estimates | |
| Godrej Consumer Products: Weak revenue print across the board |
| | 1QFY17 disappoints on revenues; EBITDA and PAT in line on the back of cost cuts | | | Even a 'sharp recovery starting next half' thesis not enough to justify current valuations; SELL | |
| Muthoot Finance: On an uptrend |
| | In a sweet spot | | | Challenges in forecasting NIM is our key concern | | | Raising near-term estimates, ADD | |
| Shriram City Union Finance: Strong business momentum, all priced in |
| | Strong loan growth and lower cost of borrowings drive earnings | | | Positive on growth trajectory | | | Provisions coverage levels remain the key sensitivity | | | Business going strong, await better entry points | |
| Dr Lal Pathlabs: Growth trajectory continues |
| | 1QFY17 - revenues in line, higher margin drives PAT above estimates | | | Healthy growth in mature region of Delhi-NCR; patient growth robust | | | Increase estimates by 4-7%; downgrade to REDUCE post sharp rally | |
--
You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to
longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at
https://groups.google.com/group/longterminvestorsresearch.
For more options, visit
https://groups.google.com/d/optout.
No comments:
Post a Comment